Edina H. Moylett
Baylor College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Edina H. Moylett.
Clinical Infectious Diseases | 2003
Edina H. Moylett; Susan E. Pacheco; Barbara A. Brown-Elliott; Tracy R. Perry; E. Stephen Buescher; Mary C. Birmingham; Jerome J. Schentag; Joseph F. Gimbel; Aaron Apodaca; Margot Schwartz; Robert M. Rakita; Richard J. Wallace
Linezolid is an oxazolidinone that has activity against most gram-positive bacteria, including in vitro activity against all Nocardia species and strains. We describe 6 clinical cases of nocardiosis that were successfully treated with linezolid. Two patients had underlying X-linked chronic granulomatous disease, and 2 patients were receiving chronic corticosteroid therapy. Four of 6 patients had disseminated disease, and 2 of these 4 patients had multiple brain abscesses. Four patients primarily received monotherapy; for the fifth patient, linezolid was added to a failing multiple-drug regimen, and, for the sixth patient, it was used as part of combination therapy. All 6 patients were successfully treated, although 1 patient had a presumed relapse of central nervous system infection after premature discontinuation of the drug. Linezolid appears to be an effective alternative for the treatment of nocardiosis.
Clinical Infectious Diseases | 2000
Marisol Fernandez; Edina H. Moylett; Daniel E. Noyola; Carol J. Baker
Candidal meningitis may complicate systemic candidiasis in the premature neonate. We conducted a 10-year retrospective review of 106 cases of systemic candidiasis in neonates to define the incidence, clinical features, laboratory findings, treatment, and outcome of candidal meningitis. Twenty-three of the 106 neonates had candidal meningitis (0.4% of admissions to the neonatal intensive care unit). The median gestational age was 26.2 weeks, the median birth weight was 820 g, and the median age at the onset of illness was 8 days. Clinical disease was severe and commonly was manifested by respiratory decompensation. Findings of cerebrospinal fluid (CSF) analyses varied: pleocytosis was inconsistent, hypoglycorrhachia was common, gram staining was uniformly negative, and Candida was isolated from 17 neonates (74%). Each infant was treated with amphotericin B (median cumulative dose, 30 mg/kg); 5 also received flucytosine therapy. In conclusion, initial clinical features of candidal meningitis are indistinguishable from those of other causes of systemic infection in premature neonates, and normal CSF parameters do not exclude meningitis. Timely initiation of amphotericin B monotherapy was associated with an excellent outcome.
Clinical Infectious Diseases | 2001
Daniel E. Noyola; Marisol Fernandez; Edina H. Moylett; Carol J. Baker
A retrospective review of 86 neonates with candidemia hospitalized from January 1989 through June 1999 was conducted to determine the frequency of ophthalmologic, visceral, or cardiac involvement. Retinal abnormalities were observed in 4 (6%) of the 67 infants in whom indirect ophthalmoscopy examination was performed. Abdominal ultrasound abnormalities were detected in 5 (7.7%) of 65 infants. Echocardiogram revealed thrombi or vegetations in 11 (15.2%) of 72 infants. Age at onset, presence of central venous catheters, and species of Candida were not predictors for involvement at these sites. Infants with candidemia that lasted > or =5 days were more likely to demonstrate ophthalmologic, renal, or cardiac abnormalities than those with a shorter duration. Infants with involvement of these organs received larger cumulative doses of amphotericin B than those without detectable abnormalities. Because complication of disseminated candidiasis by eye, renal, or cardiac involvement has therapeutic implications, and because risk factors for candidemia inadequately predict these complications, evaluations are indicated for all neonates with candidemia.
Clinical Infectious Diseases | 2000
Edina H. Moylett; Marisol Fernandez; Marcia A. Rench; Melissa E. Hickman; Carol J. Baker
Recurrent invasive disease due to group B Streptococcus (GBS) in twin infants has not been reported. We report 2 cases of recurrent GBS afflicting both siblings of a set of dichorionic twin infants. The maternal and infant colonizing and invasive strains were identical by serotyping and pulsed-field gel electrophoresis (PFGE). Despite attempts at eradication with different antibiotic regimens, the infants remained colonized after treatment of the second episode. A 5-year review of recurrent invasive GBS disease in infants in our affiliated hospitals was undertaken, and 6 further cases were identified. Serotyping and PFGE of isolates from initial and second episodes were genotypically identical for each case. Three infants each had GBS serotype Ia or V disease and 2 had GBS serotype III disease. The exact pathogenesis of recurrent GBS disease remains unclear, but our data support the hypothesis that persistent mucosal colonization with the original GBS strain rather than new acquisition is a pivotal factor in disease recurrence.
Pediatric Infectious Disease Journal | 2001
Edina H. Moylett; Taylor Chung; Carol J. Baker
Primary sternal osteomyelitis (PSO) is rare. In a 9-year-old boy with Staphylococcus aureus bacteremia, magnetic resonance imaging helped to promptly establish the diagnosis of PSO. Eleven previously reported cases are reviewed, emphasiz ing surgical drainage and antimicrobial therapy for optimal outcome. Magnetic resonance imaging may be superior to other imaging studies for the diagnosis of PSO.
Pediatric Asthma, Allergy & Immunology | 2002
Edina H. Moylett; William T. Shearer
Since the availability of specific virologic assays for the diagnosis of human immunodeficiency virus infection, the diagnosis of neonatal infection is more specific and confirmed at an earlier age. An early diagnosis of human immunodeficiency virus infection has important implications for the initiation of antiretroviral therapy. Whereas the diagnosis of this infection is primarily antibody-based prior to 18 months of age, the diagnosis at less than 18 months is virologically based.
Pediatric Research | 1999
Edina H. Moylett; Alan M. Jewell; Tony A Piedra
Do Heparin-Like Receptors Play a Role in the Attachment of Respiratory Syncitial Virus to Epithelial Cells?
Antiviral Research | 2004
Philip R. Wyde; Edina H. Moylett; Srikrishna N. Chetty; Alan M. Jewell; Terry L Bowlin; Pedro A. Piedra
Clinical Immunology | 2004
Edina H. Moylett; Anita N Wasan; Lenora M. Noroski; William T. Shearer
Pediatric Infectious Disease Journal | 2000
Edina H. Moylett; Susan N. Rossmann; Howard R. Epps; Gail J. Demmler